A Modular Platform to Fast-Track Bispecific Antibody Development
Home | A Modular Platform to Fast-Track Bispecific Antibody Development
Bispecific antibodies offer transformative potential but add CMC complexity versus mAbs. We present a modular, bioinformatics-guided platform integrating ApolloX™ cell line development, automated high-throughput (HTP) screening with a pre-optimized elution strategy, and orthogonal analytics. Predict-first triage directs candidates to standard or targeted upstream /downstream modules, shortening development, improving quality, and accelerating IND/GMP readiness.